Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza ... in the U.S., Hoge said Moderna is engaging closely with the FDA to ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Experts said that COVID-19 vaccines are expected to be effective against this variant known as "nimbus." Here's what to know about it.

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines. The FDA is expanding warnings on Pfizer and ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

Discover the latest FDA warning updates for COVID vaccines including increased health risks and new restrictions for healthy ...

The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.

The Trump administration is continuing to make its imprint on U.S. vaccine policy in recent days. The moves could change what ...